| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 7 Jul 2025 | 27 May 2025 |
| Nectar Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 inter alia to consider and approve the Audited Financial Results for the Financial Year 2024-25 Financial Statements of the Company for the Financial Year 2024-25 and matters related thereto. Please find attached herewith the reason for delay in financial results for the quarter and year ended on March 31, 2025. Please find attached herewith change in Directors as per letter. Further, please also be informed that the Audit Committee and Board of Directors could not approve and take on record the Audited Financial Results and Financial Statements for the quarter and year ended March 31, 2025. Therefore, the meetings stand adjourned sine die, for said matters. The reasons for delay in submission of financial results is being submitted by way of separate letter. The date of adjourned Board Meeting shall be intimated in due course of time. The trading window closure period is being extended accordingly till 48 hours after the declaration of Financial Results for the period ended on March 31, 2025 (As per BSE Announcement Dated on 30/05/2025) Nectar Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/07/2025 ,inter alia, to consider and approve the Audited Financial Results for the Financial Year 2024-25, Financial Statements of the Company for the Financial Year 2024-25 and matters related thereto (As Per BSE Announcement Dated on :03.07.2025) Financial Results for the Year 2024-25 Please find attacherewith letter w.r.t.: 1. Transfer of the active pharmaceutical ingredients and formulations Business on a slump sale basis; 2. Sale, transfer and delivery of Menthol Assets. (As per BSE Announcement Dated on 07/07/2025) | ||
| Board Meeting | 31 Jan 2025 | 24 Jan 2025 |
| NECTAR LIFESCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2025 inter alia to consider and approve Financial Results for the quarter and nine months ended on December 31 2024 and Other Business Matters. Outcome of Board Meeting (As per BSE Announcement Dated on 31/01/2025) | ||
| Board Meeting | 14 Nov 2024 | 4 Nov 2024 |
| NECTAR LIFESCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve the Financial Results for the quarter and half year ended on September 30 2024 and other business matters. Outcome of Board Meeting dated November 14, 2024 (As Per Bse Announcement Dated on 14.11.2024) | ||
| Board Meeting | 14 Aug 2024 | 3 Aug 2024 |
| NECTAR LIFESCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve We wish to inform you that a meeting of the Board of Directors of the company will be held on Wednesday August 14 2024 to consider and approve inter alia amongst other items: 1. the Unaudited Financial Results for the quarter ended on June 30 2024 and matters related thereto; and 2. to convene the Annual General Meeting on September 21 2024 and matters related thereto. Please find attached herewith the financial results for the quarter ended on June 30, 2024 (As Per BSE Announcement Dated on 14.08.2024) | ||
The facility was inspected primarily to assess its compliance with European Good Manufacturing Practices (EuGMP).
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
